A study in NSCLC highlighted the control of Fra-2 expression by TGF-β1 and elucidated its involvement in promoting TGF-β1-mediated migration of NSCLC cells via its association with Smad3 [109]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.